PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-21.6%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$2.63B
AUM Growth
+$2.63B
(-30%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
51.5%
Holding
141
New
26
Increased
20
Reduced
29
Closed
42
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$105M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$56.5M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$43.8M |
| 4 |
Allogene Therapeutics
ALLO
|
$41.6M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$30.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$65.9M |
| 2 |
CORI
Corium International, Inc.
CORI
|
$60.5M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$43.4M |
| 4 |
Intuitive Surgical
ISRG
|
$41.6M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$37.2M |
Sector Composition
| 1 | Healthcare | 95.05% |
| 2 | Financials | 0.08% |
| 3 | Consumer Discretionary | 0.06% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $315M | 12% | 4,608,554 -168,700 | -4% | -$11.5M |
|
|
GBT
2
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $223M | 8.48% | 5,425,726 +276,816 | +5% | +$11.4M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $192M | 7.3% | 20,724,424 +30,000 | +0.1% | +$278K |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $138M | 5.26% | 3,790,216 -17,416 | -0.5% | -$635K |
|
|
5
Iovance Biotherapeutics
IOVA
$807M
| $108M | 4.12% | 12,241,111 +4,950,912 | +68% | +$43.8M |
|
|
6
Solid Biosciences
SLDB
$427M
| $105M | 4.01% | +3,927,222 | New | +$105M |
|
7
Crinetics Pharmaceuticals
CRNX
$2.92B
| $77.6M | 2.95% | 2,587,953 | – | – |
|
|
QTNT
8
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $66M | 2.51% | 10,789,054 +2,000,000 | +23% | +$12.2M |
|
|
AMRN
9
Amarin Corp
AMRN
$311M
| $64.6M | 2.46% | 4,875,600 +4,265,400 | +699% | +$56.5M |
|
10
Ascendis Pharma
ASND
$11.8B
| $63M | 2.4% | 1,052,647 -20,000 | -2% | -$1.2M |
|
|
ARNA
11
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $55.6M | 2.12% | 1,430,171 +63,193 | +5% | +$2.46M |
|
12
argenx
ARGX
$43.6B
| $53.9M | 2.05% | 560,941 | – | – |
|
|
MYOK
13
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $53.5M | 2.04% | 1,075,216 -13,953 | -1% | -$694K |
|
14
Merit Medical Systems
MMSI
$5.36B
| $52.2M | 1.99% | 949,198 -45,000 | -5% | -$2.47M |
|
15
Travere Therapeutics
TVTX
$1.56B
| $49.8M | 1.89% | 3,342,038 +129,167 | +4% | +$1.92M |
|
16
MeiraGTx Holdings
MGTX
$587M
| $45.3M | 1.73% | 4,703,398 | – | – |
|
17
CytomX Therapeutics
CTMX
$336M
| $43.6M | 1.66% | 2,911,715 +250,000 | +9% | +$3.74M |
|
|
BPMC
18
DELISTED
Blueprint Medicines
BPMC
| $43.5M | 1.65% | 857,326 -83,821 | -9% | -$4.25M |
|
|
19
Allogene Therapeutics
ALLO
$251M
| $41.6M | 1.58% | +1,543,790 | New | +$41.6M |
|
|
LJPC
20
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $41M | 1.56% | 4,313,611 | – | – |
|
|
XLRN
21
DELISTED
Acceleron Pharma Inc.
XLRN
| $39.9M | 1.52% | 905,017 -623,188 | -41% | -$27.5M |
|
|
ALBO
22
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $39.5M | 1.5% | 1,704,330 | – | – |
|
|
VBIV
23
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $38.3M | 1.46% | 23,951,556 +14,285,713 | +148% | +$22.9M |
|
|
ATNX
24
DELISTED
Athenex, Inc. Common Stock
ATNX
| $32.6M | 1.24% | 5,096,022 +2,226,494 | +78% | +$14.2M |
|
|
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $31.1M | 1.18% | 2,825,000 +2,800,511 | +11,436% | +$30.9M |
|